0001711677-19-000001.txt : 20191127 0001711677-19-000001.hdr.sgml : 20191127 20191127111616 ACCESSION NUMBER: 0001711677-19-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20191127 DATE AS OF CHANGE: 20191127 EFFECTIVENESS DATE: 20191127 FILER: COMPANY DATA: COMPANY CONFORMED NAME: H.I.G. BioHealth Partners III, L.P. CENTRAL INDEX KEY: 0001711677 IRS NUMBER: 384016387 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-326761 FILM NUMBER: 191254400 BUSINESS ADDRESS: STREET 1: C/O H.I.G. CAPITAL, L.L.C. STREET 2: 1450 BRICKELL AVENUE, 31ST FLOOR CITY: MIAMI STATE: FL ZIP: 33131 BUSINESS PHONE: 305-379-2322 MAIL ADDRESS: STREET 1: C/O H.I.G. CAPITAL, L.L.C. STREET 2: 1450 BRICKELL AVENUE, 31ST FLOOR CITY: MIAMI STATE: FL ZIP: 33131 D/A 1 primary_doc.xml X0708 D/A LIVE 0001711677 H.I.G. BioHealth Partners III, L.P. C/O H.I.G. CAPITAL, L.L.C. 1450 BRICKELL AVENUE, 31ST FLOOR MIAMI FL FLORIDA 33131 305-379-2322 DELAWARE None None Limited Partnership true 2016 SAMI MNAYMNEH c/o H.I.G. CAPITAL, L.L.C. 1450 BRICKELL AVENUE, 31st FLOOR MIAMI FL FLORIDA 33131 Executive Officer Director CO-PRESIDENT AND DIRECTOR OF THE MANAGER OF THE GENERAL PARTNER OF THE ISSUER ANTHONY TAMER c/o H.I.G. CAPITAL, L.L.C. 1450 BRICKELL AVENUE, 31st FLOOR MIAMI FL FLORIDA 33131 Executive Officer Director CO-PRESIDENT AND DIRECTOR OF THE MANAGER OF THE GENERAL PARTNER OF THE ISSUER RICHARD SIEGEL c/o H.I.G. CAPITAL, L.L.C. 1450 BRICKELL AVENUE, 31st FLOOR MIAMI FL FLORIDA 33131 Executive Officer VP AND GENERAL COUNSEL OF THE MANAGER OF THE GENERAL PARTNER OF THE ISSUER Pooled Investment Fund Private Equity Fund false Decline to Disclose 06b 3C 3C.7 true 0001711677-18-000001 2018-11-29 true true true false 0 300000000 128750000 171250000 false 16 0 0 36000000 true Estimated aggregate mgmt. fees over the first 6 years of the term of the Issuer based on aggregate commitments of $300,000,000. Additional fees are payable for the remainder of the term of the Issuer as described in its confidential offering material. false H.I.G. BioHealth Partners III, L.P. /s/ Richard Siegel RICHARD SIEGEL VP and Gen. Counsel of the Manager of the GP of the Issuer 2019-11-27